Welcome to our dedicated page for Elevra Lithium news (Ticker: ELVR), a resource for investors and traders seeking the latest updates and insights on Elevra Lithium stock.
Elevra Lithium Limited reports news as a North American lithium producer with American Depository Shares traded under ELVR. Recurring updates center on North American Lithium, including spodumene concentrate production, sales, operating costs, safety performance, cash flow, and expansion studies.
Company news also covers quarterly activities reports, project updates for Carolina Lithium, Moblan, Ewoyaa, and Western Australian tenements, offtake and downstream processing discussions, presentation-currency changes, capital actions, and governance matters following the completed Sayona-Piedmont merger.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) has purchased and terminated Waratah’s Moblan spodumene offtake rights. Moblan is 60% owned by Elevra and 40% by Investissement Québec.
Elevra will issue Waratah US$5m in shares and US$0.5m in options, regaining 100% of its attributable Moblan offtake and removing a life-of-mine 5% price discount.
Elevra Lithium (ASX:ELV, NASDAQ:ELVR) released an updated Scoping Study for expanding the North American Lithium mine, outlining a three-stage, staged growth plan.
The study lifts incremental post-tax NPV(8%) to C$969M, total project NPV(8%) to C$3,112M, targets 338 ktpa concentrate, maintains total CAPEX at US$270M, and projects a 42% post-tax IRR with 25‑month payback.
Elevra Lithium (NASDAQ:ELVR, ASX:ELV) agreed to sell its entire interest, including offtake rights, in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt for approximately US$71 million in cash before fees and taxes.
Completion is subject to Ghanaian regulatory approvals and is expected by the end of Q1 FY27, enabling Elevra to focus on core North American assets, simplify its portfolio, and remove ongoing Ewoyaa funding obligations.
Almonty Industries (Nasdaq: ALM) appointed Jorge Beristain, CFA, as Chief Financial Officer effective June 1, 2026, with Guillaume de Lamaziere serving as Interim CFO until then. The company expects its flagship Sangdong Mine to generate revenue in 2026 as Almonty scales production across South Korea, the United States, Portugal, and Spain.
Brian Fox departed as CFO effective immediately. Management highlights Beristain’s finance, capital markets, and mining-sector experience to support Almonty’s next growth phase.
Elevra Lithium (ASX: ELV; NASDAQ: ELVR) reported improved March 2026 quarter operations with record revenue of US$81.0M (up 22% QoQ) and YTD revenue US$167M (+68% YTD). Spodumene production was 47,332 dmt (up 7% QoQ) at 5.0% grade and mill utilisation hit 94%. Cash balance was US$113M.
The company reaffirmed FY26 guidance: production 180,000–190,000 dmt, sales 170,000–190,000 dmt, unit costs US$860–880/dmt, and capex US$26M. Key milestones include a staged NAL expansion program and Ewoyaa mining lease ratification.
Elevra Lithium (NASDAQ:ELVR) will release its March 2026 Quarterly Activities Report on Thursday, 23 April 2026. The company will host an investor webcast at 9:30am AEST (23 April) — 7:30pm ET (22 April) for North American viewers.
Retail investors can register to listen live via the webcast link and submit written questions during the session. An archived recording will be available about two hours after the webcast ends. Investors are advised to log in at least five minutes early. For enquiries contact Andrew Barber, Investor Relations.
Elevra Lithium (NASDAQ:ELVR) signed a non-binding Memorandum of Understanding with Mangrove Lithium to supply up to 144,000 tpa of spodumene concentrate from North American Lithium, ramping to that level by 2030 and representing ~46% of estimated sales volumes.
The proposed five-year supply would commence in 2028, is subject to Mangrove's final investment decision by June 2027, includes a floor and ceiling price to support NAL cashflow, and anticipates Mangrove converting feedstock into 20,000 tpa of battery-grade lithium. Test work on NAL spodumene is due Q3 CY26.
Elevra Lithium (NASDAQ: ELVR) reported a record December 2025 quarter at North American Lithium (NAL) with US$66m revenue, 66,016 dmt sold at an average realised price of US$998/dmt.
Operationally, ore mined was 389,801 wmt (+15% QoQ) but recovery fell to 62% (down 7% QoQ) and concentrate production declined to 44,154 dmt (down 15% QoQ). Group cash was US$81m and capex was US$7m. FY26 guidance was revised: production 180,000–190,000 dmt, sales 170,000–190,000 dmt, and unit cost guidance US$860–880/dmt.
Elevra Lithium (NASDAQ:ELVR) said its December 2025 Quarterly Report will be released on 28 January 2026 AEDT and an investor webcast will commence at 10:30am AEDT the same day; a live link and archived webcast will be available via the company website.
The company changed its presentation currency to USD effective 1 July 2025, applied retrospectively under Australian Accounting Standards, so the December 2025 Quarterly and FY26 half‑year results will be presented in USD with translated historical comparatives included.
Elevra Lithium (NASDAQ:ELVR) announced an accelerated, staged expansion of the North American Lithium (NAL) site that uses new permitting information plus existing permits to fast-track production and lower unit costs. Key milestones: an initial 15–20% production uplift above current levels starting mid-CY27, further milling expansion to 6,500 tpd to target 315 ktpa spodumene by early CY28 using a temporary mobile crusher, and final replacement with a new crushing and ore-sorting circuit by early CY29. C1 unit cash costs were revised to US$630/t (previously US$562/t); AISC remains US$680/t. Reported project economics remain: NPV ≈ US$950M and IRR 26.4%. An updated scoping study and detailed engineering are planned for Q2 CY26.